Analytical Data
-
Gene name
CG-4
- Application
-
Alternative Names
CG-4；C7orf20；CEE；TRC35；Golgi to ER traffic Protein 4 homolog
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P25974
-
Expression Region
24-439aa
-
AA Sequence
LKVREDENNPFYLRSSNSFQTLFENQNGRIRLLQRFNKRSPQLENLRDYRIVQFQSKPNTILLPHHADADFLLFVLSGRAILTLVNNDDRDSYNLHPGDAQRIPAGTTYYLVNPHDHQNLKIIKLAIPVNKPGRYDDFFLSSTQAQQSYLQGFSHNILETSFHSEFEEINRVLFGEEEEQRQQEGVIVELSKEQIRQLSRRAKSSSRKTISSEDEPFNLRSRNPIYSNNFGKFFEITPEKNPQLRDLDIFLSSVDINEGALLLPHFNSKAIVILVINEGDANIELVGIKEQQQKQKQEEEPLEVQRYRAELSEDDVFVIPAAYPFVVNATSNLNFLAFGINAENNQRNFLAGEKDNVVRQIERQVQELAFPGSAQDVERLLKKQRESYFVDAQPQQKEEGSKGRKGPFPSILGALY
-
Molecular Weight
55.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CG-4 recombinant protein is a fusion protein derived from the human CG-4 gene, which is implicated in various developmental processes and cellular signaling pathways. Researchers have shown significant interest in CG-4 due to its potential roles in neurogenesis and its association with certain neurological disorders. The study of CG-4 protein is particularly relevant in the context of brain development, as it may be involved in the differentiation and maturation of neural cells. Advances in recombinant DNA technology have allowed for the efficient production of CG-4 as a recombinant protein, enabling researchers to investigate its functional properties and interactions in cellular systems. Understanding the molecular mechanisms of CG-4 can provide insights into its therapeutic potential for conditions like neurodegeneration or cognitive impairments. Furthermore, studies focusing on CG-4 may contribute to the development of novel biomolecular tools and therapeutic strategies aimed at enhancing neural repair and regeneration. Overall, the investigation of CG-4 recombinant protein stands at the intersection of molecular biology, neurobiology, and therapeutic innovation, paving the way for future advancements in the treatment of neurological disorders.
